SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-15-048795
Filing Date
2015-08-13
Accepted
2015-08-13 11:01:30
Documents
1
Period of Report
2015-08-12

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v418104_4.html 4  
1 OWNERSHIP DOCUMENT v418104_4.xml 4 3172
  Complete submission text file 0001144204-15-048795.txt   4878
Mailing Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170 212-584-4171
Caladrius Biosciences, Inc. (Issuer) CIK: 0000320017 (see all company filings)

IRS No.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8090 Services-Misc Health & Allied Services, NEC
Assistant Director 9

Mailing Address C/O ORTHOFIX INC. 800 BOYLSTON STREET, 39TH FLOOR BOSTON MA 02199
Business Address
VATERS ROBERT S (Reporting) CIK: 0001200883 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33650 | Film No.: 151049356